Optimizing Alveolar Ridge Expansion
Launched by HAWLER MEDICAL UNIVERSITY · Jul 4, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods to help adults with narrow jawbones get dental implants more effectively. When someone’s jawbone is too thin, it can be hard to place implants securely. The trial compares a technique called Magneto-Dynamic Ridge Splitting, which uses a special tool called a Magnetic Mallet, with another method called Osseodensification that uses Versah drills. The researchers want to find out which method better preserves the bone’s width after surgery, provides stronger initial implant stability, and encourages healthy soft tissue around the implant.
Adults aged 18 to 70 who need dental implants but have a narrow jawbone (between 4 and 6 millimeters wide) and good overall health may be eligible to participate. Participants will have surgery to expand their jawbone using one of the two techniques, followed by immediate implant placement. They will have scans before and four months after surgery to check bone changes, tests to measure how stable the implant is, and scans to see how the surrounding gum tissue responds. People with certain health conditions, heavy smokers, pregnant women, or those with untreated oral infections won’t be eligible. This study aims to help improve the success and comfort of dental implants for people with narrow jawbones.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 to 70 years.
- • Partially edentulous patients requiring ridge expansion prior to dental implant placement.
- • Alveolar ridge width between 4 mm and 6 mm as measured on CBCT.
- • Sufficient vertical bone height for implant placement without the need for vertical augmentation.
- • Adequate oral hygiene and commitment to postoperative care and follow-up visits.
- • Signed informed consent form.
- Exclusion Criteria:
- • Presence of systemic conditions contraindicating oral surgery (e.g., uncontrolled diabetes, immune-compromised status).
- • History of bisphosphonate therapy or radiation therapy to the head and neck region.
- • Active periodontal disease or untreated oral infections.
- • Heavy smokers (more than 10 cigarettes per day).
- • Pregnant or breastfeeding women.
- • History of substance abuse or psychiatric disorders that could impair compliance with study protocol.
About Hawler Medical University
Hawler Medical University is a prominent academic institution dedicated to advancing medical education, research, and clinical practice in the Kurdistan Region of Iraq. As a clinical trial sponsor, the university prioritizes the integration of innovative research methodologies to enhance healthcare outcomes. Committed to ethical standards and scientific rigor, Hawler Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct impactful clinical trials that address pressing health challenges. Through its initiatives, the university aims to contribute to the global body of medical knowledge while fostering a culture of inquiry and excellence in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erbil, , Iraq
Patients applied
Trial Officials
Jodal Ahmed, PhD
Study Director
Oral and Maxillofacial Surgery Department, College of Dentistry, Hawler Medical University, Erbil, Kurdistan Region, Iraq.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported